Drugs / Blood component A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03992001 | May 2018 → Jul 2019 | beta-thalassemia major | Università degli Studi di Ferrara | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Blood component A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03992001 ↗ |